Stockscreener 앱 받기
21.23
2.30%
-0.50
시간 외 거래:
21.23
전일 마감가:
$21.73
열려 있는:
$21.8
하루 거래량:
298.12K
Relative Volume:
0.72
시가총액:
$1.04B
수익:
$96.21M
순이익/손실:
$-12.13M
주가수익비율:
-67.83
EPS:
-0.313
순현금흐름:
$10.64M
1주 성능:
-1.48%
1개월 성능:
+7.55%
6개월 성능:
-18.09%
1년 성능:
-11.13%
1일 변동 폭
$21.00
$21.80
1주일 범위
$20.76
$23.15
52주 변동 폭
$17.86
$29.62
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
21.23 | 1.06B | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2024-09-30 | 개시 | H.C. Wainwright | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-11 | 개시 | Craig Hallum | Buy |
| 2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-19 | 개시 | B. Riley Securities | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-18 | 개시 | Cowen | Outperform |
| 2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-08 | 재확인 | Maxim Group | Buy |
| 2020-02-24 | 개시 | Lake Street | Buy |
| 2020-02-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 재개 | B. Riley FBR | Buy |
| 2020-01-08 | 개시 | Stephens | Overweight |
| 2019-11-21 | 개시 | Oppenheimer | Outperform |
| 2019-07-22 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 재확인 | Maxim Group | Buy |
| 2017-09-19 | 재확인 | Maxim Group | Buy |
| 2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
| 2017-03-10 | 재확인 | Maxim Group | Buy |
| 2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
How Biolife Solutions Inc. (BLFS) Affects Rotational Strategy Timing - Stock Traders Daily
A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum - Yahoo Finance
Lake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS) - The Globe and Mail
BioLife Solutions, Inc. (BLFS) tops Q1 earnings and revenue estimates - MSN
BioLife Solutions (BLFS) Q4 Profit Challenges Ongoing Loss Narrative - Sahm
BioLife Solutions Earnings Call Highlights Growth Path - TipRanks
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BioLife Solutions Q1 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: BioLife Solutions Q1 2026: Revenue Surges, Stock Rises - Investing.com
Earnings call transcript: BioLife Solutions Q1 2026: Revenue Surges, Stock Rises By Investing.com - Investing.com South Africa
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone - ChartMill
BioLife Solutions Q1 Earnings Call Highlights - Yahoo Finance
BioLife Solutions reports Q1 2026 revenue $27.5M, adjusted EBITDA $6.2M, GAAP net income $1.2M - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q1 Revenue $27.5M, vs. FactSet Est of $25.7M - marketscreener.com
Q1 2026 growth lifts BioLife Solutions (NASDAQ: BLFS) back to profit - Stock Titan
BioLife Solutions (NASDAQ: BLFS) grows Q1 2026 revenue 25% - Stock Titan
Biolife Solutions, Inc. Reiterates Earnings Guidance for 2026 - marketscreener.com
BioLife Solutions earnings up next as profitability test looms By Investing.com - Investing.com South Africa
BioLife Solutions earnings up next as profitability test looms - Investing.com
Invesco reports 2.35M BioLife shares (NASDAQ: BLFS) holding 4.9% - Stock Titan
MSN Money - MSN
Wall Street analysts think BioLife Solutions (BLFS) could surge 70.78%: Read this before placing a bet - MSN
BioLife Solutions 2025 Executive Compensation, Company Objectives, and Pay-for-Performance Practices Detailed - Minichart
Executive pay, bonuses and board structure at BioLife Solutions (NASDAQ: BLFS) - Stock Titan
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - Zacks Investment Research
Human Biopreservation Market 2026- 2033 Overview: Share, Size, - openPR.com
Discover BioLife Solutions And 2 Other Stocks That May Be Priced Below Their Estimated Value - Sahm
BioLife Solutions schedules May 7 earnings call, webcast at 4:30 ET - Stock Titan
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 - Financial Times
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase - The Malaysian Reserve
BIOLASE Inc (BIOL) - Minichart
BioLife Solutions Inc (BLFS) Stock Up 3.2% and Still Undervalued -- GF Score: 75/100 - GuruFocus
Utah Medical Gains 32% in a Year: Should You Buy the Stock? - TradingView
Aug Weekly: What is the PEG ratio of BioLife Solutions Inc2026 WrapUp & High Accuracy Swing Trade Signals - baoquankhu1.vn
Is BioLife Solutions Inc (BLFS) a Bargain After 3.7% Drop? GF Va - GuruFocus
[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity - Stock Titan
BioLife Solutions (BLFS) EVP has 515 shares withheld for taxes - Stock Titan
BioLife (NASDAQ: BLFS) CFO RSU vesting triggers tax withholding - Stock Titan
Weekly Earnings: Does BioLife Solutions Inc offer margin of safety2026 Review & Safe Capital Growth Tips - baoquankhu1.vn
Levels Update: Is BioLife Solutions Inc a cyclical or defensive stockEarnings Trend Report & Weekly High Potential Alerts - baoquankhu1.vn
Chipmakers Recap: Is BioLife Solutions Inc a stock for growth or value investors2026 Rallies & Precise Buy Zone Identification - baoquankhu1.vn
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):